OTCMKTS:RHHVF Roche (RHHVF) Stock Price, News & Analysis $320.19 +3.52 (+1.11%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$319.72▼$325.1350-Day Range$248.36▼$320.1952-Week Range$233.12▼$325.13Volume79,498 shsAverage Volume8,086 shsMarket CapitalizationN/AP/E Ratio29.62Dividend Yield2.44%Price TargetN/A Stock AnalysisStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest Get Roche alerts: Email Address Roche MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestBearishDividend StrengthWeakBased on Four FactorsSustainabilityN/ANews Sentiment-0.50Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.06 out of 5 stars N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Roche.Read more about Roche's stock forecast and price target. Previous Next 0.0 Short Interest Percentage of Shares ShortedShort Interest Ratio / Days to CoverRoche has a short interest ratio ("days to cover") of 240.4, which indicates bearish sentiment.Change versus previous monthShort interest in Roche has recently increased by 26.14%, indicating that investor sentiment is decreasing significantly. Previous Next 1.7 Dividend Strength Dividend YieldRoche pays a meaningful dividend of 3.21%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthRoche does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Roche is 72.16%. This payout ratio is at a healthy, sustainable level, below 75%.Read more about Roche's dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for RHHVF. Previous Next 0.8 News and Social Media Coverage News SentimentRoche has a news sentiment score of -0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Roche this week, compared to 1 article on an average week. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Roche insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 29.01% of the stock of Roche is held by institutions.Read more about Roche's insider trading history. Previous Next 1.3 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Roche is 29.62, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 142.35.Price to Earnings Ratio vs. SectorThe P/E ratio of Roche is 29.62, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 156.32. Previous Next See Top Rated MarketRank™ Stocks Here Ad Unstoppable Prosperity“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. About Roche Stock (OTCMKTS:RHHVF)Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.Read More RHHVF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RHHVF Stock News HeadlinesJuly 26 at 2:52 AM | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF) and Aquestive Therapeutics (AQST)May 22, 2024 | finance.yahoo.comRoche Holding AG (ROG.SW)July 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.May 22, 2024 | seekingalpha.comGLP-1 Drug Development Market Pile-Up ContinuesMay 20, 2024 | markets.businessinsider.comCiti Remains a Buy on Roche Holding AG (RHHVF)May 18, 2024 | seekingalpha.comRoche Is Joining The Obesity Party But Questions RemainMay 16, 2024 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: Roche Holding AG (OtherRHHVF), Adaptimmune Therapeutics (ADAP) and GoodRx Holdings (GDRX)April 26, 2024 | seekingalpha.comAbbVie's Q1: Positive SurpriseJuly 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.April 24, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Neurocrine (NBIX), Day One Biopharmaceuticals (DAWN) and Roche Holding AG (OtherRHHVF)April 24, 2024 | markets.businessinsider.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Fate Therapeutics (FATE), Danaher (DHR) and Roche Holding AG (OtherRHHVF)April 17, 2024 | seekingalpha.comTempest Therapeutics: Multiple 2024 Catalysts Make This A Must WatchApril 13, 2024 | morningstar.comRoche Holding AG RHHVFApril 12, 2024 | markets.businessinsider.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Bristol-Myers Squibb (BMY) and Roche Holding AG (OtherRHHVF)March 31, 2024 | seekingalpha.comOutlook Therapeutics: De-Risked Regulatory Tracks Are Lining Up For Possible ONS-5010 ApprovalMarch 20, 2024 | markets.businessinsider.comLonza To Acquire U.S. Biologics Site From Roche For $1.2 BlnMarch 17, 2024 | seekingalpha.comPoseida: April 2024 Data Could Shed Light On Differentiated CAR-T AdvancementMarch 11, 2024 | seekingalpha.comInternational Wide-Moat Stocks On Sale - The March 2024 Heat MapSee More Headlines Receive RHHVF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Roche and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - General Sub-IndustryPersonal Services Current SymbolOTCMKTS:RHHVF CUSIPN/A CIKN/A Webwww.roche.com Phone(161) 688-1111FaxN/AEmployees103,605Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio29.29 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesDr. Severin Schwan Ph.D. (Age 57)Executive Chairman Comp: $8.25MDr. Thomas Schinecker (Age 49)Chief Executive Officer Comp: $4.25MDr. Alan Hippe (Age 57)Chief Financial & Information Officer Comp: $4.51MDr. Bruno EschliHead of Investor RelationsMs. Claudia Bockstiegel (Age 60)General Counsel Ms. Pascale Schmidt (Age 51)Chief Compliance Officer Ms. Barbara Schadler (Age 62)Head of Group Communications Ms. Cristina A. Wilbur (Age 57)Chief People Officer Comp: $3.21MDr. Nicolas DunantHead of Group Media RelationsMr. Boris L. Zaitra (Age 52)Head of Group Business Development and M&A More ExecutivesKey CompetitorsAstraZenecaOTCMKTS:AZNCFDaiichi SankyoOTCMKTS:DSNKYDechra PharmaceuticalsOTCMKTS:DCHPFJCR PharmaceuticalsOTCMKTS:JCRRFKyowa KirinOTCMKTS:KYKOFView All Competitors RHHVF Stock Analysis - Frequently Asked Questions How have RHHVF shares performed this year? Roche's stock was trading at $285.00 on January 1st, 2024. Since then, RHHVF stock has increased by 12.3% and is now trading at $320.19. View the best growth stocks for 2024 here. How do I buy shares of Roche? Shares of RHHVF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:RHHVF) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roche Holding AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Roche With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
